Geyser Brands Inc. (TSX.V: GYSR) Developing, Marketing Leading Cannabis Products and Brands

  • Geyser Brands focuses on creating first-rate, cannabis-led health care products and brands
  • The company leverages a proprietary, all-natural NanoFusion nano-emulsion delivery system
  • Geyser is pursuing an acquisition of Solace Management Group Inc.

Geyser Brands Inc. (TSX.V: GYSR) is a foremost consumer health care company based in Vancouver, British Columbia. The company has an integrated production chain and formulation lab that develops unique products using hemp cannabidiol (CBD) for healthy lifestyle brands. Fundamentally, Geyser Brands builds and markets some of the leading cannabis products and brands in the world. Its proprietary nanotechnology formulations create products with superior bioavailability and efficacy. The company’s vision is to secure top positions in every market it enters (http://cnw.fm/HUtZ3).

Geyser’s NanoFusion advanced delivery system rapidly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency. NanoFusion provides premier bioavailability and solves problems with insolubility. It also provides a longer shelf life, stability of molecules and enhanced permeation that allows for deeper skin penetration. Moreover, NanoFusion​ improves the transport of active ingredients for site-specific targeting and delivers active ingredients across cell membranes for release within the cell. Its proprietary process creates the only all-natural nano-emulsion on the market.

Geyser Brands’ acquisition target is Solace Management Group Inc. Solace owns a varied set of brands and is a leader in cannabis product formulations and development. Its brands span the adult-recreational and medical cannabis markets, as well as pet-health and wellness and hemp markets. Solace’s brands include Apawthecary Pets, WildTails pet products, Apothecary Naturals and Apothecary Ink.

Solace’s cosmetics line is Apothecary Naturals, whose products include pain creams, lip balms and skin health products for men and women. Its pet line, Apawthecary Pets, supplies leading retail stores and vets in Canada with products for pain and anxiety. Its baked pet treats use a proprietary process for baking in the hemp without degrading the molecule, delivering dosage control and better quality.

Geyser Brands’ global market focus is hemp oil for worldwide brands, with CBD as a value-added ingredient where legal. The company has a portfolio of products in the pain relief, skin health, sleep, anxiety and pet health categories. The company’s goal is to leverage its knowledge and experience with cannabis, and its licensed production facility for manufacturing and distribution, to deliver cannabis health care products for the everyday consumer. Geyser’s tinctures, creams, cosmetics, functional foods and beverages, and natural health products are made with all-natural, biocompatible, biodegradable, nontoxic and noninflammatory materials.

Geyser Brands subsidiary Apothecary Botanicals operates a Health Canada-approved licensed production facility based just outside of Vancouver, British Columbia. It received its cultivation license in 2018 and its processing license in June 2019. It is currently completing laboratory modifications in anticipation of receiving an R&D license in the short term.

Through Solace Management Group, Geyser Brands recently announced the world’s first hemp-infused, freeze-dried pet food (http://cnw.fm/4PMys). Upon completion of the Solace acquisition, Geyser anticipates that WildTails’ products will use its proprietary NanoFusion technology to infuse hemp into proteins such as beef, chicken and fish. Negotiations for order-and-distribution contracts are expected to be announced in Q3 2019.

Geyser Brands presents an intriguing investment opportunity as it establishes new brands with hemp ingredients in a variety of markets. One of 150 Health Canada-approved cannabis LPs, the company has a strong footprint in Canada as it expands its existing markets. Geyser continues to focus on building an integrated production chain and formulation lab that will develop innovative products for its customers.

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.canadiancannabiswire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.canadiancannabiswire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

Archives

Select A Month

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977